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Abstract
The interaction between fungal pathogens with the host frequently results in morphological changes, such as hyphae
formation. The encapsulated pathogenic fungus Cryptococcus neoformans is not considered a dimorphic fungus, and is
predominantly found in host tissues as round yeast cells. However, there is a specific morphological change associated with
cryptococcal infection that involves an increase in capsule volume. We now report another morphological change whereby
gigantic cells are formed in tissue. The paper reports the phenotypic characterization of giant cells isolated from infected
mice and the cellular changes associated with giant cell formation. C. neoformans infection in mice resulted in the
appearance of giant cells with cell bodies up to 30 mm in diameter and capsules resistant to stripping with c-radiation and
organic solvents. The proportion of giant cells ranged from 10 to 80% of the total lung fungal burden, depending on
infection time, individual mice, and correlated with the type of immune response. When placed on agar, giant cells budded
to produce small daughter cells that traversed the capsule of the mother cell at the speed of 20–50 m/h. Giant cells with
dimensions that approximated those in vivo were observed in vitro after prolonged culture in minimal media, and were the
oldest in the culture, suggesting that giant cell formation is an aging-dependent phenomenon. Giant cells recovered from
mice displayed polyploidy, suggesting a mechanism by which gigantism results from cell cycle progression without cell
fission. Giant cell formation was dependent on cAMP, but not on Ras1. Real-time imaging showed that giant cells were
engaged, but not engulfed by phagocytic cells. We describe a remarkable new strategy for C. neoformans to evade the
immune response by enlarging cell size, and suggest that gigantism results from replication without fission, a phenomenon
that may also occur with other fungal pathogens.
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Introduction
The interaction between a microbe and a host involves a
complex response by both the pathogen and the infected
individual. The host has multiple defence mechanisms to avoid
infection, damage and disease. Microbial pathogens adapt to
survive in a host through multiple changes that include signalling
pathways that confer the capacity to survive immune-mediated
stresses. Both entities, the host and the microbe, interact and each
contributes to the outcome of infection [1].
In the case of fungal pathogens, the interaction with the host
frequently results in morphological changes. For example, Candida
albicans forms pseudohyphae and true hyphae during infection,
phenomena associated with virulence [2,3,4]. Other examples of
fungal pathogens that form filaments during infection are
Aspergillus species and the agents of zygomycosis. In contrast,
Histoplasma capsulatum and Blastomyces dermatitidis manifest a
temperature regulated dimorphism, such that at ambient temper-
atures they form filaments and at 37uC transform into yeast cells
[5,6,7]. Although the role of these morphological transitions is not
completely understood, it is believed that the phenomenon of
fungal dimorphism plays an important function during the
interaction of each of these microbes with their host.
The fungus Cryptococcus neoformans is the causative agent of
cryptococcosis, a disease responsible for over 600,000 deaths per
year, which makes this pathogen a major global threat.
Cryptococcosis is currently the fourth leading cause of death from
infectious diseases in Sub-Saharan Africa [8]. C. neoformans is
unique among the major fungal pathogens in that it possesses a
polysaccharide capsule surrounding a yeast cell body [9]. Capsular
polysaccharides are also released into host tissues [10,11,12],
where they mediate numerous deleterious effects on host immune
function [13,14,15]. In fact, the polysaccharide capsule is the
factor that makes the greatest contribution to the virulence of C.
neoformans [16].
Although C. neoformans can form pseudohyphae during mating
[9], this pathogen is mainly found in host tissues as round yeast
cells. However, there is a specific morphological change associated
with cryptococcal infection that involves a significant increase in
capsule volume. Capsule size in C. neoformans depends on the
growth condition (reviewed in [17]). While capsule size is relatively
small in standard laboratory media and in the environment, it
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infection [18], such that it can comprise more than 90% of the
total volume of the cell [19]. Capsular enlargement is believed to
confer an advantage to the microorganism during its interaction
with the host. For example, capsule growth interferes with
complement-mediated phagocytosis [20] and protects the yeast
cell against free radicals and antimicrobial agents [21]. Further-
more, increased capsule size makes the yeast more difficult to
phagocytose by a variety of phagocytic cells, including amoebas
that can prey upon C. neoformans in the environment [21].
We now report another morphological change whereby gigantic
fungal cells are formed in tissue. This change is achieved, not only
by a significant increase in capsule size, but also by an enlargement
of the cell body. During pulmonary infection, we observed that a
significant proportion of yeasts in the lung had cell volumes 900-
fold larger than cells grown in standard laboratory conditions. In
retrospect, giant cells have been noted in prior studies
[18,22,23,24,25], but were never isolated or studied. The
emergence of fungal giant cells poses a formidable problem for
the immune system. In this study we present experimental
evidence suggesting that C. neoformans gigantism may be a strategy
that confers upon the organism the ability to survive within the
host for long time periods.
Results
C. neoformans produce gigantic cells during infection
While the typical size of C. neoformans cells ranges between 4–8
microns (Figure 1A), we confirm the existence and report the
recovery of C. neoformans cells of enormous size formed during
infection (Figure 1B). Although these cells manifested a large
increase in capsule size, there was also a concomitant increase in
cell body size. The cell body reached 25–30 mm in diameter,
which was almost 7-fold greater than the 4.5 mm average size
observed in vitro. This effect was more dramatic if the size of the
capsule was included, with the giant cell size typically ranging from
40 to 60 mm in diameter, although extremely large cells with
diameters around 70–100 mm were occasionally observed. If one
considers volume applying the formula for a sphere (V=
4/36p6(r
3)), then giant cell formation involved an increase of
900-fold in cellular volume, compared to cells grown in Sabouraud
medium. We investigated whether the phenomenon was found in
different cryptococcal strains. Consequently, we infected different
individual mice with ten different C. neoformans strains (both
serotype A and D, including standard strains, such as H99, 24067
or B3501, and clinical isolates from the Yeast Collection of the
Spanish Mycology Reference Laboratory). For all strains, we
found giant cells after three weeks of infection, indicating that this
phenomenon applied to diverse strains (results not shown). Hence,
we focused our efforts on the model serotype A strain H99, and we
arbitrarily defined giant cells as those with a cell diameter greater
than 30 mm (capsule included), a size that is 5–6 times the usual
size observed in vitro, and is virtually never encountered during in
vitro experimental conditions. Using this strain, we observed giant
cell formation in four different mouse strains (CD1, BALB/c,
C57BL/6J and CBA/J), indicating that the emergence of giant
cells was also not mouse strain specific.
Morphological features of the giant cells
Giant cells had different cellular features than cells of regular
size (Figure 1). Giant cells frequently contained multiple vesicles of
unknown function that could reach more than 50 per cell
(Figure 1C). In addition, there was usually a single enlarged vesicle
that occupied a significant proportion of the cell body volume. To
better identify these intracellular structures, we stained the cells
with the vacuole specific marker MDY-64. In regular cells, we
normally observed the presence of a single vacuole (Figure 1D). In
giant cells, we observed two patterns of staining with this specific
marker (Figure 1E,F). Multiple vesicles which stained with the
vacuole marker were identified in approximately 50% of giant
cells, whereas the remainder displayed staining mainly in a single
large intracellular vesicle. These results suggest that in some giant
cells, the vacuole fragmented into multiple vesicles or the smaller
vesicles failed to coalesce.
A peculiarity of the giant cells was the abnormally large width of
their cell wall. This feature was most apparent when the cells were
observed by transmission electron microscopy. Using this
technique, we could determine that the cell wall of regular cells
had a width between 50–100 nm (Figure 1G). In contrast, the
width in giant cells was 20–30 larger, ranging from 2 to 3 mm
(Figure 1H,I). In these pictures, it was also apparent that the
density of the capsule differed between regular and giant cells. In
the case of yeast obtained in vitro, the cells displayed a low density
capsule with individual polysaccharide fibers attached to the cell
wall (Figure 1G). In giant cells, the capsule was significantly denser
in the regions close to the cell wall (Figure 1H,I).
Fungal cell suspensions recovered from the lungs of infected
mice had a dark brownish colour. We hypothesized that this
phenomenon could be due to in vivo pigment accumulation at the
cell wall level, in particular melanin [26]. To investigate this
hypothesis, we stained giant cells with specific mAbs to melanin
[27]. Giant C. neoformans cells bound mAb to melanin at the cell
wall level (Figure 1J,K), suggesting that this structure was
melanized. In addition, we observed that giant cells showed a
high degree of autofluorescence (result not shown), which has been
reported in cryptococcal cells grown in certain media [28].
Scanning electron microscopy images suggested that the capsule
of giant cells was different from that of cells grown in vitro. For
cells grown in standard Sabouraud medium we noted that the
dehydration and fixing process resulted in polysaccharide
shrinkage and aggregation of fibers such that regions of the cell
wall became exposed (Figure 2A). In contrast, the architecture of
Author Summary
In this article we describe the formation of giant cells by
the human fungal pathogen Cryptococcus neoformans
during infection, involving an approximately 900-fold
increase in volume compared to that of yeast cells grown
in vitro. This switch to gigantism is a dramatic transition
that is posited to have important consequences during
infection. The paper reports the phenotypic characteriza-
tion of these cells and the relationship between giant cell
formation and polyploidy which suggests that gigantism is
achieved by continued cell growth and DNA replication
without fission. During infection, we observed an inverse
correlation between the proportion of giant cells in the
lung of infected mice and the inflammatory response
elicited by the animals. In conclusion, our results indicate
that during infection, C. neoformans forms giant cells,
which might be implicated in fungal survival in the host
during long time periods, especially during chronic and
asymptomatic infection. The capacity for gigantism is an
important new facet in fungal pathogenesis that provides
the pathogen with the ability to escape host defences. We
propose that the transition to gigantism can have
profound consequences for the host-pathogen interaction
including promoting fungal persistence in the host that
can translate into latency and disease relapses.
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revealing a highly cross-linked polysaccharide net (Figure 2B) that
accumulated around the cell body as a very compacted layer
(Figure 2C). In addition, we frequently observed the presence of
‘‘holes’’ in the capsule (Figure 2 D, E and F), which we interpreted
as pathways formed during recent budding. Transmission electron
microscopy images confirmed that the capsule of giant cells was
denser than the capsule of in vitro cultivated cells (Figure 1 H, I).
The higher degree of cross-linking in the capsule of giant cells
relative to in vitro grown cells was confirmed by treating the cells
with DMSO or c-radiation, procedures known to strip the capsule
of cells of regular size [29,30,31]. c-radiation removed the
majority of capsule of giant cells, but the inner region of the
capsule remained attached to the cell (Figure 3). In contrast,
DMSO treatment did not affect capsular size of giant cells while it
routinely strips the capsule of cells grown in vitro (results not
shown). The increased resistance of the inner capsule to radiation
and the overall capsule to organic solvents is consistent with a
higher degree of capsular cross-linking by the giant cells.
In C. neoformans, complement deposition is affected by the
porosity and blocking capacity of the capsule [32]. Consequently,
we characterized complement localization in the capsule of giant
cells as a measure of capsule penetrability. As shown in Figure 4A,
complement is known to deposit in the inner location of the
capsule near the cell wall of typical yeast cells [20]. When giant
cells were incubated in mouse serum, we observed that
complement was not detected in the inner regions of the capsule
(Figure 4B). The exclusion of complement from the inner capsule
is consistent with reduced permeability resulting from increased
fibril cross-linking.
To ascertain whether giant cells manifested antigenic differences
from cells grown in vitro we used indirect immunofluorescence
with mAb 18B7. We compared cells of different size obtained from
the lungs of infected mice, to avoid the possibility that factors of
the immune system influenced the antigenic properties of the
capsule. When stained with mAbs 18B7, cells of small size
exhibited a uniform annular binding pattern (Figure 4C), which
was identical to the binding of this mAb to cells grown in vitro
[32]. In contrast, most of the fluorescence localized to the edge of
the giant cell capsule, and this binding was diffuse and punctate
(Figure 4D–F). Moreover, many cells showed a double ring,
punctate pattern, with a more uniform inner ring and a rougher,
more diffuse outer ring.
Chitin-like structures in the capsule were recently demonstrated
by the specific binding of fluorescent wheat germ agglutinin, which
binds to sialic acids and b-1,4-N-acetylglucosamine (GlcNAc)
oligomers [33]. We used WGA to ascertain whether these
structures were also present in giant cells. Cells grown in vitro
bound WGA, especially at the neck between the mother cell and
the bud (Figure 4G). In giant cells, these structures were
particularly prominent. Protrusions into the capsule were longer,
reaching several microns (Figure 4H).
Replication of giant cells
Giant cells were viable, since they replicated when placed on
fresh agar plates. Daughter cells emerging from giant cells were
Figure 1. Morphological features of giant cells from infected
mice. A) Cells grown in vitro in Sabouraud medium. B) Cell obtained
from the lungs of a mouse infected with C. neoformans (10
5 cells/mouse)
5 weeks earlier. C) Photomicrographs of a giant cell illustrating the
presence of multiple vesicles (highlighted with arrows) within giant cells.
Scale bar, 10 mm. D, E and F, vacuole staining with MDY-64 dye. Yeast
cells isolated from the lung of mice four weeks after infection with 10
5
yeast cells were stained with the specific vacuole marker MDY-64 as
described in Materials and Methods. Localization of the signal was
performed by confocal microscopy. D) Cell of regular size. E and F) Giant
cells. In all the cases, regular light microscopy, fluorescence and the
merge of both images are shown. Scale bars in the left panels applies to
the corresponding middle and right panels. G, H and I, transmission
electronmicroscopy ofthe capsuleandcellwallofregularandgiantcells.
Cells grown in vitro or giant cells obtained from the lungs of mice three
weeks after infection were fixed and processed for TEM. G, cell grown in
vitro; H, giant cell; I, magnification of the cell wall region of the giant cell
shown in B. CP, capsule; CW, cell wall; CY, cytoplasm. The rectangle
indicates the width of the cell wall. J,K, staining of giant cells with anti-
melanin mAb. J, light microscopy; K, fluorescence. Scale bar, 10 mm.
doi:10.1371/journal.ppat.1000945.g001
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traversed it in less than 0.08 seconds (Figure 5A and B,
supporting Videos S1 and S2). In some cells, movement through
the capsule was much faster, taking less than 0.01 seconds
(Figure 5C, supporting Video S3). By measuring the distance
travelled through the capsule by emerging buds and the transit
time we estimated that the daughter cells traversed the capsule at
20–50 m/h, which is a remarkably high velocity for a
microscopic unicellular particle in a gelatinous environment.
This data suggested the existence of a motive force propelling and
separating the buds from the mother cell’s capsule. We observed
that giant cells could produce several daughter cells over brief
periods of time (2–3 hours), with buds always emerging from the
same cell site (data not shown). Despite ejection, the daughter
cells remained close to the capsule of the mother cells where they
replicated, producing abundant progeny around the giant cells.
Even after the giant cells were surrounded by daughter cells, new
buds were still ejected with significant force, since they were able
Figure 2. Scanning electron microscopy of cells grown in vitro and of giant cells. A) Cell in vitro grown in Sabouraud. B-F) Giant cells
isolated from lung. Scale bar in panel B (10 mm) also applies to panels C-F.
doi:10.1371/journal.ppat.1000945.g002
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supporting Video S4).
When placed on agar, we observed that not all giant cells
produced daughter cells after 24 h, suggesting that some of these
cells were metabolically arrested, or had died prior to or during the
isolation procedure. To measure the percentage of replicating cells
we obtained giant cells from two mice and counted the proportion
of giant cells producing colonies after 24 h on agar with a
microscope. The percentage of giant cells reproducing was 60%
and 73% for each mouse, respectively, indicating that the majority
of giant cells were viable.
As a secondary technique for testing giant cell viability we used
the method based on the reduction of 2,3-bis(2-methoxy-4-nitro-5-
sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt (XTT) by
alive cells. Giant cells manifested a strong capacity to reduce XTT,
which was approximately 100-fold greater than the activity shown
by the same number of cells grown in vitro (data not shown). This
result indicates that giant cells are metabolically active.
In vitro cellular growth in minimal media and its relation
to cell aging
We tried to induce giant cell formation in vitro by incubating
the cells in different media. When we incubated the cells in
minimal media, around 4–5% of the cells showed a marked
increased in cell size over 4 days. These cells reached up to 25–
30 mm in diameter (capsule included), approximating, but not
quite reaching the size of the giant cells recovered from mouse
lungs. In addition, these in vitro giant cells showed other
phenotypic differences with the giant cells obtained in vitro, such
a smaller capsular size and a lack of enlargement of the cell wall
(result not shown). Although this in vitro medium only partially
reproduced the gigantism phenomenon, we used it to study if there
was any relationship between cellular enlargement and the age of
the cells. We hypothesized that massive cellular growth required a
prolonged period of time, so the majority of the giant cells
obtained would be originated from the initial inocula. To explore
this hypothesis, we labelled the cells with complement. Comple-
ment proteins, especially C3, bind to the capsule covalently
without inhibiting cell growth and do not segregate to buds after
replication [34]. Consequently, we labelled cells grown in
Sabouraud medium with mouse C3 and then incubated them in
minimal medium (which induces a small population of giant-like
cells) and Sabouraud medium. At time zero, all the cells were
labelled with complement (Figure 6A), but after 4 days of
incubation in minimal medium, only a few cells remained labelled
(Figure 6B). When we measured the average size of the cells with
complement bound after four days of incubation in minimal
medium, we found that these cells had a significant larger size than
the cells incubated in Sabouraud medium (Figure 6B). We
repeated this experiment, placing the cells in parallel in minimal
medium, which induces cell enlargement in some cells, and in
Sabouraud medium, in which cell enlargement is not expected.
Then, we measured cell size of complement-labelled and non-
labelled cells. In minimal medium, we observed that the
complement-stained cells were significantly larger than the
unlabelled population (Figure 6C, D). Large cells were not found
in Sabouraud medium after C3 labelling and there was no
difference in the size of cells with and without C3 labelling
(Figure 6C, D). This result indicates that cellular enlargement and
giant cell formation is correlated with the age of the cells, such that
the giant cells are the older cells in the culture.
DNA content
We hypothesized that giant cell formation was a consequence of
continued cell cycle progression without cellular fission. In other
fungi, cell size can be related to DNA content [35,36]. Using flow
cytometry to measure DNA content, we found that giant cells had
low permeability to propidium iodide by regular staining protocols
(results not shown), but could be permeabilized by heating at 60uC
for 45 minutes. As mentioned above, cells from the lungs of mice
infected for 3–4 weeks showed strong autofluorescence, so we
measured the intensity of the signal in the presence or absence of
propidium iodide. We first analysed the difference in the forward
scatter (FSC, cell size) and side scatter (SSC, cell complexity).
When we compared these parameters, we observed a population
of larger yeasts in the cells isolated from the lung that was not
present in the yeast cells obtained in vitro, as was expected with
the presence of giant cells in vivo (Figure 7A, B). This population
was defined as region 1 (R1), which contained the giant cells
present in the population. To estimate the DNA content, we
added propidium iodide to these samples. When we measured the
propidium iodide staining, we found that there was a high
variation in the DNA content in the cell population obtained from
lungs (Figure 7C), which implied a high variation in the DNA
content of cells in vivo. Fungal cells isolated from the lungs of
infected mice also displayed significant autofluorescence in the
absence of propidium iodide staining. To assess the staining of
giant cells, we subtracted the autofluorescence of the cells present
in region 1 from the fluorescence value determined in the presence
of propidium iodide. The mean fluorescence intensity for the giant
cells was almost 10
3 fold higher than the signal measured in cells
grown in vitro (Figure 7D). This result suggested that giant cells
contain multiple copies of DNA. To quantify the ploidy level of the
giant cells further, we performed real time PCR to amplify the
ITS1 region from ribosomal DNA. We included controls of
purified genomic DNA of known concentrations, which yielded a
lineal relationship between crossing point values and DNA
concentration. When we compared 300 giant and regular cells
Figure 3. Capsule release by c-radiation. Cells of in vitro-enlarged
capsule (A) and giant cells (B) were exposed to c-irradiation, suspended
in India ink, and observed under the microscope. Images of
representative cells are shown before (control, left panel) and after
irradiation (c-irradiation, right panel).
doi:10.1371/journal.ppat.1000945.g003
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in giant cells versus 40.00 in regular in vitro grown cells). When we
estimated the amount of DNA present in each condition according
to a standard curve generated using different concentrations of
genomic DNA, we calculated that the amount of DNA in each
giant cell was 1.3610
27 ng. In contrast, in vitro cultivated cells
contained 8.4610
29 ng. This result indicated that giant cells
contained 166 DNA than regular cells. This experiment was
repeated using different cell concentrations and consistent results
were obtained (result not shown).
DAPI was used to directly observe the nucleus of the giant cells.
This staining revealed that both regular (Figure 7E) and giant cells
(Figure 7F) contained a single nucleus.
Signal transduction pathways involved in giant cell
formation
We investigated the potential involvementof twoof the majorsignal
transduction pathways in C. neoformans (cAMP and Ras1 [37,38]) in
giant cell formation. Ras1-deficient cells produced giant cells in the
lungs of infected mice (Figure 8A). In contrast, mutants unable to
accumulate cAMP (lacking adenylate cyclase encoded by the CAC1
gene) did not produce giant cells during murine infection (Figure 8A),
suggesting that this pathway was required for giant cell formation.
The absence of giant cells in mice infected with the cAMP
mutant was associated with a reduced fungal burden. Hence, the
lack of giant cells with this mutant in vivo might be related to the
ability of the host to rapidly clear the fungus. For this reason, we
examined whether a cac1 mutant formed giant cells in minimal
media. The cac1 mutant failed to produce giant cells, whereas a
significant proportion of cells of the wild type (H99) and
reconstituted (cac1/CAC1) strains manifested cellular enlargement
(Figure 8B), confirming that cAMP pathway is involved in giant
cell formation. To further characterize this phenotype, we
analysed the forward and side scatter profile of the cells from
the three strains by flow cytometry, since this type of plot allows for
clear differentiations in cell size. As shown in Figure 8C, the cac1
Figure4. Differences in capsular structurebetween regular andgiant cells. Yeast cells from lung extracts were incubated in mouse serum and
labelled with antibodies to C3 and GXM. A) cell of a regular size; B) giant cell. Light microscopy and complement localization (green fluorescence) and
capsule edge (red fluorescence) are shown. C–H) capsular features shown by fluorescence. C–F) Indirect immunofluorescence with GXM-binding mAbs.
MAb 18B7 labelling of cells of regular size (C) or giant cells (D–F) isolated from lung of infected mice. Light microscopy and fluorescence pictures are
shown for each cell. G–H) Binding of wheat germ agglutinin to C. neoformans. The presence of chitin-like structures in the capsule was studied by the
binding of WGA to the cells as described in Materials and Methods. G) Cells grown in Sabouraud and then transferred to 10% Saboraud buffered at
pH 7.3 with 50 mM MOPS buffer to induce capsule enlargement. H) A representative giant cell isolated from the lungs of infected mice. Arrows indicate
the major regions where WGA binds to the cells. Scale bars in C–D in light microscopy panels denote 5 microns and apply to the fluorescence images.
doi:10.1371/journal.ppat.1000945.g004
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FSC and SSC values. In contrast, the wild type and reconstituted
strains produced more heterogeneous populations, in which cells
with larger FSC and SSC values were measured, indicating the
appearance of cells of larger size.
Distribution of fungal cell size during infection and
correlation with inflammation
The distribution of cell sizes in vivo was extremely variable
depending on the experimental conditions. Under our standard
conditions (infection of 6–8 weeks old mice with 10
5 yeast cells) we
consistently found that the proportion of giant cells in the lung was
between 1–10%, with variation between individual mice and
between experiments. However, in several experiments, we
occasionally found that the proportion of giant cells was higher
than 90% of the lung fungal cell population. Curiously, in those
experiments where the proportion of giant cells was very high,
there were no obvious signs of disease and the mice looked
healthy. We decided to investigate this observation in more detail
by studying the relationship between inoculum and giant cell
Figure 5. Time lapse images of replicating giant cells in vitro. Giant cells were obtained from lungs of four weeks-infected mice and placed
on Sabouraud plates. After 18 h, the growing colonies were monitored under the microscope. The digital videos were processed with Windows
Movie Maker software. This software allowed the conversion of the videos into single pictures, each one represented as a different frame of the video.
The number in each picture corresponds to the time in seconds. A, B and C correspond to three different budding events. Corresponding videos are
included as supporting information files.
doi:10.1371/journal.ppat.1000945.g005
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reproduce chronic or latent asymptomatic infections. For this
purpose, we performed infections with high (10
6/mouse) or a low
dose (10
4 cells/mouse).
Mice infected with high inocula consistently developed typical
cryptococcal disease, as indirectly shown by progressive weight loss
(Figure 9A). However, we found a high variation in outcome when
the mice were infected with a low inoculum. Most of these mice (2
of 3) developed disease comparable with that seen after infection
with a high dose. Severe disease was characterized by dense
inflammation in the lungs, increasing the size and weight of these
organs (1.3–1.8 grams) such that they accounted for 7–8% of the
total body weight (Figure 9B). In contrast, the lung mass of
asymptomatic mice (control mice and one of the mice infected
with low inocula) was approximately 0.45 grams and ,1% of total
body weight. As expected, mice developing severe disease had a
significantly higher number of CFUs (.10
6/lung) than the mice
that did not manifest obvious signs of disease, where the number of
CFUs remained very low (,10
4) during the experiment
(Figure 9C). When we recovered the fungal cells from the lungs
of these mice, we found profound differences in the size of the
yeast cells. The average cryptococcal cell size in mice receiving a
high inoculum was around 15–20 mm, which was significantly
larger than the size reached when grown in vitro in rich medium
(Figure 9D, Sabouraud medium). Although approximately 5–20%
of the yeast cells met criteria for giant cells, the enlargement of the
majority of cells isolated was mainly due to increase in the capsule
size, so the size of these populations was only slightly different from
the size reached when capsule size is induced overnight in vitro
(see Figure 9D, in vitro enlarged capsule size). We were able to
isolate around 1-3610
3 C. neoformans cells from the lungs of
asymptomatic, low dose infected mice and the average yeast cell
size was around 40 mm (Figure 9D). Notably, approximately 70%
of the isolated yeast cells were giant forms.
We also analysed the proportion of giant cells in the lungs using
Classification and Regression Trees (CART) analysis. Using this
approach, we found that there was a strong association between
the total fungal cell size in the lungs and the degree of
inflammation, such that high inflammation was predicted when
the average fungal cell size was below 36 mm (Figure 9E). This
prediction is in accordance with our initial criteria of defining
giant cells as those with a cell diameter greater than 30 mm. When
we plotted the corresponding ROC curve, we found that the
region under the curve was 0.80, which provides strong support
for the prediction. On the other hand, the model could not
efficiently predict the proportion of giant cells according to
inflammation, due to the low number of yeast cells found in lungs
without significant inflammation.
The relationship between the proportion of giant cells and
inflammation was confirmed histologically. In control mice, the
lungs revealed the typical structure in which alveolar spaces were
present throughout the lungs (Figure 10). In the infected mice, we
only observed this benign histology in the asymptomatic mouse
(mouse 1 of the group infected with 10
4 yeast cells, Figure 10). In
the rest of the low dose (Figure 10) and all of the high dose infected
mice (result not shown), dense inflammation was observed and
alveolar spaces contained numerous yeast cells and inflammatory
cells.
We performed another experiment using older mice (14–16
weeks old), which are more resistant to infection, and a lower
infective dose than in the experiment previously described. We
infected with either a low (10
3 cells/mouse, 10 mice) or a high
dose (10
5 cells/mouse, 3 mice), and measured fungal cell size after
a month of infection. In this new model, the mice did not develop
Figure 6. Giant cell formation in vitro. Cells from H99 strain were
grown in Sabouraud, washed and labelled with mouse serum. C3
deposition was then detected by immunofluorescence (A). After
incubation in mouse serum, cryptococcal cells were transferred to
minimal medium (MM) for four days, and C3 was detected (B). Scale bar
in A and B, 10 mm, and apply to the corresponding fluorescence panels.
C) Cells were grown and labelled as in A (Day 0 sample), transferred to
Sabouraud or MM for 4 days at 37uC, and the cell size was measured in
the C3 labelled population (‘‘MM, C3 labelled’’ and ‘‘Sab, C3 labelled’’)
and in the whole population, including both C3 labelled and unlabelled
cells. The average and the standard deviation (error bars) are plotted
and p-values for the highlighted comparisons are shown. At least, 20–
50 cells were counted, except in the ‘‘Sab, C3 labelled’’ samples, where
C3 positive cells were rarely identified due to the overgrowth of the
culture. Kruskall-Wallis test was used to assess statistical differences. D)
Scatter representation showing all the cells plotted in panel B. The line
in each sample denotes the average of the distribution.
doi:10.1371/journal.ppat.1000945.g006
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PLoS Pathogens | www.plospathogens.org 8 June 2010 | Volume 6 | Issue 6 | e1000945Figure 7. Determination of DNA content by cytometry and DAPI staining. Fungal cell samples were obtained from the lungs of one mouse
3 weeks after challenge with 10
5 C. neoformans cells. As a control, cells grown for 24 hours in Sabouraud were also used. The cells were fixed after
incubation at 60uC for 45 minutes. Propidium iodide was immediately added at 10 mg/mL DNA content and the labelling was determined by the
propidium iodide fluorescence intensity. Matched samples were subjected to cytometry without propidium iodide. A) FSC/SSC plot of cells grown in
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month, only one of the mice infected with the high dose showed
inflammation in the lungs (table 1, 10
5, mouse 2). In the group
infected with low dose, we did not find yeast cells in 3 mice,
indicating that the infection had been cleared. In the other seven
mice, we found a low number of yeast cells, suggesting a chronic
asymptomatic infection. In six of the seven mice, the average size
of the fungal cells was above 30 mm, and the proportion of giant
cells was between 50–90%. When the mice were infected with a
higher dose, the two mice in which no inflammation was detected
showed fungal cell sizes above 30 mm, with a proportion of giant
cells around 70–80%. In the mouse with inflammation (mouse
number 2), the average fungal cell size was smaller (14 mm), and
the proportion of giant cells was less than 5%. This data supports
the notion that the highest proportion of giant cells is found in
hosts with chronic and longstanding infection.
Susceptibility to oxidative stress
We measured the susceptibility of giant cells to oxidative stress
produced by incubation in H2O2. Giant cells were significantly
more resistant to killing by oxidative stress than cryptococcal cells
grown in vitro, with survival rates of 19%610 and 46%614 for
cells grown in vitro and giant cells, respectively (p=0.014).
In vitro interaction of giant cells with phagocytic cells
To further characterize the interaction of giant cells with host
effector cells, we incubated macrophage-like cells with giant cells
and observed the outcome of the interaction using live-imaging
microscopy. When small-sized cryptococci were exposed to
macrophages, we observed rapid and avid phagocytosis, yeast cell
transfer between macrophages, fusion of infected macrophages
after division, and intracellular replication of the C. neoformans cells,
as described previously [39,40,41,42,43] and shown in supporting
Videos S5, S6 and S7. None of these phenomena were observed
when macrophage-like cells were exposed to C. neoformans giant
cells, indicating that the interaction between these fungal cells and
macrophages was different and had different outcomes. Although
in some cases the macrophages seemed to adhere to the giant
fungal cells, there was no phagocytosis or macrophage fusion after
division (supporting Videos S8 and S9), indicating that macro-
phages could not cope with the giant cells.
Discussion
Cryptococcus neoformans giant cells have been occasionally
described in the literature primarily as curiosities in histological
tissue sections [22,23,24], but their importance in pathogenesis has
remained obscure. Apart from the fundamental problems in cell
biology posed by the mechanisms responsible for the transition to
gigantism, we considered that the presence of fungal giant cells
would pose a major problem for the immune system simply by
virtue of their size.
Giant cell formation was associated with several changes to the
capsule relative to the typical cells observed in vitro. These
changes represented an exaggerated response in capsule, cell body,
and cell wall size during infection. Moreover, the resistance to
capsule shedding after c-radiation exposure suggests a more
compact and dense structure. Such an increase in capsular
compactness could confer a survival advantage in vivo since the
capsule is known to protect against oxidative fluxes of the types
produced by immune effector cells [21]. Consistent with this idea,
we have observed that giant cells are more resistant to oxidative
stress.
Giant cells maintained their enormous size ex vivo, although they
produced smaller cells in agar at replication rates similar to those
observedinvitro.Anotherremarkableaspectofthebuddingprocess
is the rapidity with which the buds traversed the capsule, especially
considering the denseness and compactness of the polysaccharide
noted by scanning and transmission electron microscopy. However,
we did observe holes in the capsules of giant cells with dimensions
that approximated the size needed for daughter cells to emerge.
Similar capsule holes have been occasionally described in
encapsulated cells grown in vitro [44]. The strong binding of
WGA to these cells also suggests the presence of chitin-like
structures, which have been proposed to be involved in the
movement of the bud through the capsule of the mother cell [33].
Given prior work noting tunnel-like structures formed around buds
[33,34], it is possible that the rapid egress of buds from the mother
cells represent movement along such structures that provide a non-
obstructed conduit through the capsule.
The cellular mechanisms by which cryptococcal cells enlarge to
gigantic sizes are not known and a complete understanding of this
phenomenon is beyond the scope of the current work. Neverthe-
less, we explored the potential mechanism of cell division without
fission as a way for progressively increasing mass. Cell growth is
intimately dependant on the cell cycle. The cells need to reach a
critical size for cell cycle to progress, and there is a constant ratio
between the mass of the cell and its DNA content (reviewed in
[45,46,47,48]). In plants, the phenomenon is striking, because
their cells can enlarge in size by 100- or even 1000-fold, and this is
achieved by endoreduplication, which is the process in which the
cell increases the ploidy of the cells through several rounds of DNA
replication [49]. Recently, it has been shown that bacteria from
the genus Epulopiscium, which grow to lengths of 200–300 mm and
widths of 40–50 mm, have extreme polyploidy, generating tens of
thousands of copies of their genome [50]. In a process that may be
relevant to cryptococcal gigantism, there are some symbiotic
bacteria that undergo an important differentiation process
achieved by genome amplification by endoreduplication in plant
nodules resulting in significant cell enlargement [51] and provide
beautiful examples of how some factors of symbiotic plants
regulate the cell cycle of their symbiotic microorganisms.
We hypothesized that giant C. neoformans cells achieved their size
by repeatedly entering G1 cycles without dividing. To investigate
this possibility we stained cells for DNA. Cells recovered from
infected animals produced a noisy FACS profile that was
interpreted as being consistent with cell-to-cell variation in DNA
content. By analyzing cell size and fluorescence intensity we
showed that cell size correlated with DNA content, thus
establishing that larger cells have more DNA, a result confirmed
by real-time PCR. These findings are consistent with a mechanism
for DNA replication without cell fission.
Sabouraud. B) FSC/SSC of cryptococcal cells from lungs. Region 1 delimits all the cells whose size and complexity are not found in cultures grown in
vitro and presumably cover all the cells with increased cell size. C) Propidium iodide fluorescence intensity of the four samples analyzed: in vivo
isolated cells (plus and minus propidium iodide) and in vitro cells (plus and minus propidium iodide). D) Propidium iodide fluorescence intensity of
the cells from the lung present in R1. E–F) DAPI staining. Yeast cells obtained from the lungs of mice infected with 10
5 yeast cells were stained with
DAPI. E) cell of regular size; F) giant cell. Corresponding light microscopy and fluorescence images are shown. Scale bar in the light microscopy panels
apply to the fluorescence images.
doi:10.1371/journal.ppat.1000945.g007
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PLoS Pathogens | www.plospathogens.org 10 June 2010 | Volume 6 | Issue 6 | e1000945Figure 8. Giant cell formation depends on cAMP, but not Ras1. C57BL/6J mice were infected with H99, ras1 (Ras1 mutant) and cac1
(adenylate cyclase mutant) strains (10
6 per mouse). After three weeks, the mice were sacrificed and fungal cells were isolated. Representative pictures
of fungal cells are shown. A) India ink microscopy, scale bar in left panel applies to all the pictures. B) Cell size distribution of wild type, cac1 mutant
and its reconstituted strain (cac1/CAC1) after 5 days of growth in minimal medium at 37uC. The cells were suspended in India Ink to delimit the
capsule, and the diameter of the cells (capsule included) was measured microscopically. C) Forward Scatter/Side Scatter plot of cac1 mutants after
incubation in minimal medium. The cells described in B were analysed by flow cytometry to obtain the corresponding forward scatter (FSC, correlated
with cell size) and side scatter (SSC, correlated with cell complexity).
doi:10.1371/journal.ppat.1000945.g008
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lung was a function of total microbial burden and pulmonary
inflammation. Okagaki et al also found differences in giant/titan
cell proportions during infection experiments with MATa and
MATa strains, with the proportion of titan cells being higher when
mice were co-infected with both mating types (Okagaki et al, see
related article in the current PLoS Pathogens issue). These authors
have concluded that titan cell formation is induced by the
pheromone signalling pathway. Taking our and their results
together, we can conclude that gigantism is a morphological
response to host environments that impact cAMP and pheromone
signalling pathways, which could regulate the cell cycle with the
final purpose of generating giant cells during infection. The fact
that the survival of the host is not compromised when the
proportion of giant cells is high suggests that giant cells can survive
in a local environment in the host for protracted periods of time
without disseminating in the setting of intact host immunity, a
finding in agreement with Okagaki’s report. This notion is
consistent with reports that a moderate increase in cell size due
to capsule enlargement interferes with C. neoformans dissemination
from the lung [52,53].
Various studies have suggested that C. neoformans dissemination
is associated with intracellular survival inside macrophages
[54,55,56,57], but this model cannot be applied to giant cells
since they exceed the size of macrophages. Hence, the increased
size of the giant cells is likely to be an impediment for their
dissemination as they are simply too large to cross biological
barriers and/or transverse capillary diameters. Nevertheless, such
cells are viable and capable of producing small sized variants when
placed in suitable conditions, such as rich agar. Taken together,
our findings suggest that giant cell formation could provide the
fungus with a strategy for prolonged survival in a host. Cells could
conceivably survive through the life of the host and then return to
soils when an animal dies. Alternatively, the giant cells could await
Figure 9. Parameters of disease in mice infected with C. neoformans and giant cell proportion in the lungs. CD1 mice were infected with
different inocula of C. neoformans, and different parameters were monitored during the course of the infection. A) Body weight of mice infected with
a low dose (,10
4 cells, black line, closed symbols, n=3) or a high dose (10
6, grey line, grey symbols, n=3) of C. neoformans. A control mouse, injected
with PBS, is also shown (grey line, open symbols). B) Proportion of the lung weight in respect to body weight, as an indicator of lung inflammation. C)
CFUs from the lungs of mice described in A and B. D) Cell size of C. neoformans in vitro and in vivo. Cell size (capsule included) was measured in
fungal samples obtained from mice infected with high or low C. neoformans doses (see Figure 9A-C). As a control, cell size was measured in cells
grown in vitro in Sabouraud or in 10% Sabouraud buffered at pH 7 with 50 mM MOPS to induce capsule enlargement. The number expresses the
proportion of giant cells in each sample, defined as cell with a diameter above 30 mm. The line in each distribution represents the average of the
population. E) Results of the CART analysis. Left panel, prediction of the correlation between inflammation and total fungal cell size. A cell size lower
than 35.92 mm was strongly associated with increased inflammation. Right panel, corresponding ROC curve, showing a region under the curve of 0.8.
doi:10.1371/journal.ppat.1000945.g009
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PLoS Pathogens | www.plospathogens.org 12 June 2010 | Volume 6 | Issue 6 | e1000945Figure 10. Histological sections of mice infected with different C. neoformans inocula. Tissue sections from mice described in Figure 9 were
stained with hematoxylin and eosin. Tissue section of control mouse (upper left panel) and three different mice infected with a low C. neoformans
inocula. Mouse 1, upper right panel; mouse 2, middle and lower left panels; mouse 3, middle and lower right panels (for mice 2 and 3, two different
regions are shown). For each panel, a magnification of a region is shown, which is delimited by an inset. Scale bar in upper left magnification, 25 mm,
and applies to the rest of amplified panels.
doi:10.1371/journal.ppat.1000945.g010
Table 1. Fungal cell size and proportion of giant cells in 16-weeks old mice infected with low and high doses of H99 strain.
Yeast dose (cells/mouse)
10
3 10
5
Mouse number 1 2 3 4 5 6 7 1 2 3
Lung weight (mg) 240 390 326 340 339 240 309 550 860 413
Mean 6 St. Dev (mm) 34663 3 663 1 613 20654 9 694 6 610 44611 34612 14654 0 610
Giant cells (%) 61 74 50 9 91 80 90 67 4 82
Lower 95% CI 32.3 29.5 21.4 15.5 42.1 30.4 39.4 30.1 13.3 34.1
Upper 95% CI 36.3 37.3 40.5 25 57.6 62.4 49.8 37 16 46.1
Ten CD1 mice (16 weeks old) were infected with 10
3 yeast cells/mouse, and three mice were infected with 10
5 yeast cells/mouse. The animals were killed after a month,
and the weight of the lungs was measured. Fungal cells were isolated as described in Materials and Methods, and the mean value, standard deviation, proportion of
giant cells (above 30 mm), and the lower and upper 95% confidence interval were calculated. In three mice of the group infected with a low dose, we did not find any
yeast cells, so the data of the other seven mice is represented.
doi:10.1371/journal.ppat.1000945.t001
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infection, immunosuppression after organ transplant, or other
conditions impairing host immune responses that lead the fungus
to proliferate to produce abundant progeny. In this context, it is
noteworthy that micro-yeast forms have been described in the lung
of infected mice [18,58], suggesting another form of size
polymorphism at the other end of the scale. All these findings
indicate that during infection, C. neoformans can display a wide
variation in cell sizes, ranging from micro-forms to giant cells, and
suggest that each of these morphotypes have different roles in the
pathogenesis of persistence and dissemination.
We are aware of occasional reports of gigantic cells in other
fungal species. For example, giant Candida albicans cells with
diameter up to 30 mm have been described [59,60], and similar
large cells have been described for other pathogenic fungi during
infection. The arthroconidia of Coccidioides immitis and Coccidioides
posadasii swell to form giant spherules (typically 30–150 mmi n
diameter) during mammalian infection and the spherules produce
a large number of endospores derived from the cell membrane,
each with a single nucleus [35]. When the spherule is mature, the
cell membrane is dissolved and the endospores are released.
Another example of fungal giant cells occurs in species from the
genus Emmonsia, responsible for adiaspiromycosis in humans.
Emmonsia crescent cells reach up to 200–700 mm during infection
and these forms are multinucleate. Emmonsia parva forms cells up to
40 mm, and they also contain several nuclei [36]. It is possible that
gigantism is a general property of unicellular fungi that is
expressed under certain conditions. If this is the case, the
reproducibility of giant cell formation during cryptococcal
infection provides an excellent experimental system for the study
of this phenomenon.
In summary, C. neoformans cells can achieve gigantic dimensions
during infection and the phenomenon suggests that gigantism may
be considered a new form of fungal dimorphism. The occurrence
of extraordinarily large cells may enable an adaptation for
persistence in certain hosts. The findings for C. neoformans together
with the similar reports in other fungi suggest that this may be a
general mechanism for fungal survival under certain environments
and possibly contribute to persistence during host-pathogen
interactions.
Materials and Methods
Yeast strains and growth media
For most experiments, serotype A H99 strain was used [61]. In
some experiments the following strains were also used: 24067
(serotype D, ATCC); B3501 (serotype D, [62]); RPC3 (cac1::URA5,
[37]); RPC7 (cac1::URA5/CAC1, [37]); LCC1 (ras1::ADE2, [38])
and different clinical isolates from the Yeast Collection of the
Spanish Mycology Reference Laboratory (CL2132, CL4860,
CL5154, CL5632, CL5707, CL5066 and CL4979). Yeasts were
grown in Sabouraud liquid medium at 30uC with moderate
shaking (150 r.p.m.). In some cases, the yeast cells were grown in
minimal media (29.4 mM KH2PO4, 10 mM MgSO4,1 3 m M
Glycine, 3 mM thiamine, 15 mM glucose, pH 5.5). For melaniza-
tion, L-DOPA containing medium was prepared as in [63]. In
other experiments, the cells were transfer from the original
Sabouraud culture to 10% Sabouraud medium pH 7.3 with
50 mM MOPS buffer, as described in [17], to induce capsule
enlargement in vitro.
Mouse strains and infection models
Six to eight weeks old female BALB/c, C57BL/6J (Jackson
Laboratories, Bethesda, MD) and CD1 mice (Charles River
Laboratories) were used in this study. In some experiments, older
CD1 mice (16 weeks old) were also used. C. neoformans strains were
grown at 30uC, washed with sterile PBS, and suspended at specific
cell densities. Fifty microliters of the selected yeast cell suspension
were injected intratracheally into mice previously anesthetized
with a xylazine/ketamine mixture, as described [64].
Histology sections of lung tissues
Lungs were excised from mice at different infection times and
fixed in formalin for 48 h at room temperature. The tissues were
then dehydrated and embedded in paraffin using an STP120
Tissue Processor (Microm International, Walldorf, Germany).
Then, 5 mm tissue sections were obtained using a Leica RM2245
microtome and placed on glass slides. Hematoxylin/eosin staining
of the tissue sections was performed using standard protocols.
Fungal cells isolation from lungs of infected mice
Mice were euthanized at different times after infection and the
lungs were removed. Lung tissue was then homogenized in 10 mL
of PBS with 1 mg/ml collagenase (Roche, Mannheim, Germany).
The cell suspension was incubated for 1 h at 37uC with occasional
vortex agitation, and washed several times with sterile distilled
water. The cells were suspended in sterile distilled water, and
immediately placed in fixative for microscopy, in fresh medium for
microscopy observation, or in Sabouraud agar at 30uC overnight
to observe in vitro budding.
Microscopy techniques
Cells were viewed with different microscopes. In some
experiments, an Olympus AX70 microscope was used and pictures
were taken with a digital camera using QCapture Suite V2.46
software for Windows. Alternatively, a Leica DMI3000B connect-
ed to a DFC300 digital camera with LAS 3.3.1 software, or a
Leica DMI 4000B or a Leica DMRD microscope connected to a
Leica DC200 digital camera with IM1000 software were used. To
visualize the size of the capsule, the cells were mixed with an India
ink suspension. Digital Images were processed with Adobe
Photoshop 7.0 software (San Jose, CA). For confocal microscopy,
a SP5 confocal microscope (Leica Microsystems) was use.
Macrophage-like cell lines and cell culture techniques
The macrophage-like cell line RAW264.7 was maintained in
DMEM medium supplemented with 10% heat-inactivated fetal
bovine serum, 10% NTCT, and 1% of non-essential amino acids
at 37uC in the presence of a 5% CO2 atmosphere.
Live-imaging of the interaction between macrophages
and fungal cells
For phagocytosis experiments, 5610
4 macrophages were placed
on 96-well plates and incubated overnight at 37uC in the presence
of 5% CO2, so that a total number of 10
5 macrophages was
expected after this incubation given a phagocytic cell replication
time of approximately 12 h. Fungal cells were added at a 1:2
(macrophage:yeast cells) ratio in 200 mL of medium. Yeast cells of
regular size were obtained by growing in Sabouraud medium
overnight. To isolate giant cells, fungal cells were isolated from the
lungs of infected mice as described above. Giant cells were
separated from the rest of the fungal population by passing the
sample through 11 mm filters. Although we defined giant cells as
those larger than 30 mm (capsule included), we observed that the
capsule did not contribute to retention on the filters, since the size
of the cell delimited by the cell wall was the main factor associated
with retention or passage. The filters containing the giant cells
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were concentrated by centrifugation. After filtration, we observed
that the population was significantly enriched in giant cells, being
more than 90% of the sample. Finally, the cells that transited or
were retained by the filter were counted using a haemocytometer.
Once regular and giant cells were obtained and exposed to the
macrophages, the 96-wells plate was placed under a Leica DMI
4000B microscope using a 206 objective with a 5% CO2
environment and 37uC. Pictures were taken at different time
intervals (see figure legend of the corresponding supporting
videos). The videos generated by the Leica software were exported
as .avi documents and processed with ImageJ (National Institutes
of Health, USA, http://rsb.info.nih.gov/ij/index.html) and Vid-
Crop 2.1.0.0 (GeoVid) softwares. The final videos were generated
by merging 5 frames per second.
Melanin detection by immunofluorescence
Suspensions of cells isolated from mouse lung were air-dried on
poly-L-lysine-coated slides (Sigma). The slides coated with the cells
were washed in PBS, incubated in blocking buffer (Pierce,
Rockford, IL) for 1 h at 37uC followed by incubation with
10 mg/ml of the IgM melanin-binding monoclonal antibody
(mAb) 6D2 for 1 h at 37uC. MAb 6D2 was generated against
melanin derived from C. neoformans [27]. After washing, the slides
were incubated with a 1:1000 dilution of tetramethyl rhodamine
isothiocyanate (TRITC) -conjugated goat anti-mouse (GAM) IgM
(Southern Biotechnologies Associates, Inc; Birmingham, AL) for
1 h at 37uC. The slides were washed, mounted using a 50%
glycerol, 50% PBS, and 0.1 M N-propyl gallate solution, and
viewed with an Olympus AX70 microscope equipped with
fluorescent filters. Negative controls consisted of cells incubated
with mAb 5C11, which binds mycobacterial lipoarabinomannan
[65], as the primary Ab or with TRITC-labeled Ab alone.
Scanning electron microscopy
Yeast cells were washed in PBS and suspended in fixing solution
(2% p-formaldahyde, 2.5% glutaraldehyde, 0.1 M sodium caco-
lydate). Cells were then serially dehydrated with ethanol, coated
with gold palladium and visualized using a JEOL (Tokyo, Japan)
JAM 6400 microscope.
Transmission electron microscopy
Cells grown in vitro or isolated from the lungs of infected mice
(see above) were fixed with 2.5% glutaraldehyde in 0.1 M sodium
cacodylate buffer. The cells were treated with osmium tetraoxide
and serially dehydrated. The samples were embedded in epoxy
resin and ultrathin sections were obtained, stained with uranyl
acetate and lead citrate, and observed in a CM12-Phillips
transmission electron microscope.
DMSO and c-radiation treatment
Yeast cells with enlarged capsule were exposed to varying
amounts of c-radiation from
137Cs to remove layers of the
polysaccharide capsule as described [29,66]. Briefly, giant and in
vitro-grown cells were washed three times in PBS to remove shed
capsular polysaccharides, suspended in 1 mL of distilled H2O, and
irradiated using a Shepherd Mark I Irradiator at the dose rate of
1388 rads/min. For all experiments, cells were irradiated for 40
minutes. Irradiated cells were collected by centrifugation. In other
experiments, the fungal cells were suspended in DMSO as
described in [29]. The presence of capsule after the treatments
(c-irradiation or DMSO) was visually observed by suspending the
cells in India Ink and regular microscopy.
Complement labelling and detection
Complement (C3; complement protein 3) deposition on the
cryptococcal capsule was performed as in [20]. Briefly, C57BL/6J
mice were bled from the retro-orbital cavity and serum was
obtained by centrifugation. Approximately 2610
7 cryptococcal
cells were suspended in 700 mL freshly-obtained serum, and
incubated at 37uC for 1 h. Cells were extensively washed and
suspended in PBS. C3 was then detected using a fluorescein-
isothiocyanate (FITC) conjugated GAM C3 antibody (4 mg/mL,
Cappel, ICN, Aurora, OH). Yeast washed and not suspended in
serum were used as controls. To delineate the capsular edge, mAb
18B7 (10 mg/mL) specific for GXM [67] was added, and detected
using a TRITC conjugated GAM IgG1 antibody (10 mg/ml,
Southern Biotechnology Associates, Inc). The cells were observed
under fluorescent filters with the Olympus AX70 microscope,
QCapture Suite V2.46 software for Windows, and Adobe
Photoshop 7.0 for Macintosh.
Imaging of daughter cell emergence from the giant
mother cells
Yeast cells were isolated from infected mice as described above,
and placed on Sabouraud agar plates for 18 h 30uC. Initially, we
tried recording the budding of giant cells by basic microscopy
techniques, such as taking pictures every few minutes or seconds.
However, the separation of the bud through the capsule of the
giant cell was too fast, so we developed a new approach to record
the phenomenon. The surface agar plate was observed with an
Olympus AX70 microscope to visualize and continuously record
giant cells. To record real-time daughter cell emergence, the cells
were observed in the computer screen with the ‘‘Preview’’ option,
and the image of the screen was recorded with a Digital
Handycam Sony Camcorder affixed to a tripod. The videos were
converted into digital files using Windows Movie Maker software
provided by Microsoft Windows and processed with the Quick
Media Converter (V. 3.6.5) software. Although this method
provided lower resolution than the regular CCD used in
microscopy, it permitted a precise measurement of the phenom-
enon.
XTT viability assay
Giant cells were obtained by filtering the yeasts obtained from
the lung of infected mice through 22 mm filters. Then, the yeast
cells were separated from the filter by gently shaking the filters in
20 mL of water in 50 mL centrifuge tubes. After 20 minutes, the
filters were removed, and the tubes centrifuged at 2000 r.p.m.
Then, the cells were suspended in 2 mL of sterile water and the
cell concentration was estimated using a haemocytometer.
Approximately 10
5 giant cells were placed on 96 wells plates.
In parallel, regular cells were obtained by overnight incubation in
Sabouraud, washed with sterile water and counted with a
haemocytometer. Then, the same number of cells (10
5)w a s
placed in 96-wells plates. As negative controls, equal numbers of
giant and regular cells were heat-inactivated (45 minutes at 60uC)
and placed in different wells of the 96-wells plates. Viability
measurement based on the reduction of 2,3-bis(2-methoxy-4-
nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt
(XTT) by living cells was performed as described in [21] with
minor modifications, which involved the use of 1 mg/mL of
XTT and 25 mM menadione. Optical density at 450 nm was
recorded every 30 minutes for 18 hours in a iEMS Spectropho-
tometer (Thermofisher). Differences in metabolic activities were
calculated by fold differences in the optical densities of the
different wells.
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To detect capsular features, we observed the immunofluores-
cence pattern after incubating the cells with the mAb 18B7 to the
capsular polysaccharide as described above (see complement
labelling and detection section), but using goat anti-mouse IgG1-
FITC conjugated as the detection Ab. Yeast washed and
incubated with the IgG1-FITC alone were used as controls. In
some experiments, calcofluor (10 mg/mL) was included to visualize
the cell wall.
Wheat germ agglutinin staining
To observe the presence of chitin-like structures, fungal cells
with enlarged capsule (incubated in 10% Sabouradud in 50 mM
MOPS buffer pH 7.3) were treated as in [33]. Briefly, the cells
were washed with PBS and suspended in 4% p-formaldehyde
cacodylate buffer (0.1 M, pH 7.2) and incubated for 30 min at
room temperature. The fixed cells were washed in PBS and
suspended in 100 mlo fa5mg/mL of WGA conjugated to Alexa
594 (Molecular Probes, Invitrogen) for 1 hour at 37uC. Cell
suspensions were mounted over glass slides and photographed with
a Leica DMI 3000B fluorescence microscope.
Vacuole staining and visualization by confocal
microscopy
To identify the vacuole in the yeast cells, we used the specific
dye MDY-64 (Molecular Probes, Invitrogen, Eugene, Oregon)
following the manufacturer’s recommendations. Briefly, the cells
were suspended in 10 mM HEPES buffer (pH 7.4) supplemented
with 5% glucose. MDY-64 was dissolved in DMSO, and added to
10
6 cells at a final concentration of 10 mM. The cells were
incubated for 5 minutes at room temperature, and washed twice
with the same buffer. The cells were observed with a SP5 confocal
microscope (Leica Microsystems).
Cellular DNA content
Cells were isolated as described above and fixed by heating the
cells at 60uC for 45 minutes in PBS buffer. Then, the cells were
separated in two parallel samples, and propidium iodide was
added to one of them at a final concentration of 10 mg/mL. DNA
content was analyzed using a FACSCalibur cytometer (Becton
Dickinson). As a control, cells grown in vitro in Sabouraud
medium were also analyzed.
Nuclear staining
To visualize the nucleus, the cells were treated with 3.7%
formaldehyde for 30 minutes. Then, the cells were washed with
PBS and DAPI was added at 0.3 mg/mL. The cells were incubated
for 10 minutes at 37uC, and then washed twice with PBS. Finally,
fluorescence was visualized in a Leica DM3000 microscope.
Real-time PCR
Giant cells were obtained by filtering the lung extracts through
22 mm filters as above. The filters were then placed in 50 mL tubes
containing 20 mL of sterile water with moderate shaking, and
after 20 minutes, the filters were removed. The tubes were
centrifuged, and the pellet suspended in 0.5 mL of sterile water.
Then, the cell concentration was determined using a haemocy-
tometer. In parallel, cells obtained from a fresh liquid culture in
Sabouraud were counted, and a cell suspension was prepared at
the same concentration as that calculated for the giant cells. A
real-time PCR using whole cells was then designed using
equivalent numbers of the different cell types in the well. The
reaction (final volume of 20 mL) contained 2.8610
3 or 2.8610
2
cells, 1.5 mM MgCl2, and 0.8 mM of ITS1 (59TCCGTAGGT-
GAACCTGCGG39) and ITS2 (59GCTGCGTTCTTCATC-
GATGC39) oligonucleotides, which amplify the ITS1 region from
the ribosomal DNA. The real time was performed using the
SensiMix Kit (Quantance) using the enzymes and SYBR green
concentrations recommended by the manufacturer. The reaction
mix was placed in a 96-wells plate and PCR was performed in a
LC480 real-time PCR machine (Roche). We included wells with a
known concentration of C. neoformans genomic DNA (20, 2, 0.2 and
0.02 ng) to quantify the results. The PCR was performed
according to the following protocol: initial step of 10 minutes at
95uC and 45 amplification cycles (10 seconds at 95uC, 5 seconds at
54uC and 30 seconds at 72uC). Once the PCR was finished, a
standard curve was calculated using the wells of the known
genomic DNA concentration, and this curve was used to calculate
the estimate of DNA present in each of the samples.
Classification and Regression Trees (CART) analysis
The CART system was proposed by Breiman et al. [68], and is
characterized by binary-split searches, automatic self-validation
procedures and surrogate splitters. This analysis is used to find
associations between events with statistical support. CART analysis
(CART6.0Salford Systems,Ca.,USA)wasusedtofindassociations
between giant cell formation and inflammation in the lungs. This
analysis was performed with the following methodological condi-
tions, Gini method, minimum cost tree regardless of the size for
selecting the best tree, 10 v-fold-cross-validation, equal priors, no
costs, and no penalties. Relative error of 0 means no error or perfect
fit, whereas 1 represents the performance of random guessing. The
statistical support for this association is given by the ROC curve. In
this graph, specificity (false positive rate) vs. sensitivity (true positives
rate) is calculated, and the area under the curve is analysed. When
this area is 1 (100% of sensitivity and 0% false positives), a total
agreement for the prediction is obtained. An area of 0.5 or below is
indicative of random guess.
Oxidative stress susceptibility
Yeast cells (regular and giant) were obtained as described above.
The cells were incubated in PBS with or without 1 mM H2O2 at a
cell density of 10
4 cells/mL. After two hours of incubation at
37uC, 100 mL of each sample was plated on Sabouraud agar
medium. In addition, a 1/10 dilution was done in PBS, and
100 mL of this dilution was also plated. The plates were incubated
at 30uC for 48 hours and the colonies were enumerated. The
survival was expressed as the percentage of colonies counted in the
samples incubated with H2O2 compared to colonies of control
samples not exposed to the oxidative agent.
Statistical analysis
Normal distribution in group samples were assessed using the
Shapiro-Wilk and Kolmogorov-Smirnov tests using Unistat 5.0
(Unistat Ltd, London, England) and Analyse-it (Analyse-it Ltd, Leeds,
England) softwares for Excel. Statistical differences between groups
were tested using Student’s t-Test (normal distributions) or Kruskal-
Wallis test (non-parametric test for non-normally distributed samples).
Differences were considered significant when p value was below 0.05.
Ethics statement
All the experiments involving the use of animals have been
performed following the guidelines of the Bioethical and Animal
Welfare Committee of the Instituto de Salud Carlos III (approved
protocol PA-349, to be performed at the National Centre for
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Video S1 Live imaging of giant cells budding in vitro. Giant
cells were obtained from infected mice as described in Materials
and Methods and in Figure 4 legend. Live imaging of budding
was recorded and processed as described in Materials and
Methods.
Found at: doi:10.1371/journal.ppat.1000945.s001 (2.39 MB AVI)
Video S2 Live imaging of giant cells budding in vitro. Giant cells
were obtained from infected mice as described in Materials and
Methods and in Figure 4 legend. Live imaging of budding was
recorded and processed as described in Materials and Methods.
Found at: doi:10.1371/journal.ppat.1000945.s002 (0.18 MB
WMV)
Video S3 Live imaging of giant cells budding in vitro. Giant cells
were obtained from infected mice as described in Materials and
Methods and in Figure 4 legend. Live imaging of budding was
recorded and processed as described in Materials and Methods.
Found at: doi:10.1371/journal.ppat.1000945.s003 (1.71 MB AVI)
Video S4 Live imaging of giant cells budding in vitro. Giant cells
were obtained from infected mice as described in Materials and
Methods and in Figure 4 legend. Live imaging of budding was
recorded and processed as described in Materials and Methods.
Found at: doi:10.1371/journal.ppat.1000945.s004 (2.94 MB AVI)
Video S5 Phagocytosis of C. neoformans by murine-like macro-
phages. The video shows the interaction of RAW264.7 macro-
phage cell lines exposed to C. neoformans H99 strain at a ratio 1:2.
Videos were performed as described in Materials and Methods.
Pictures were taken every 5 minutes, and 5 frames per second are
shown in the video (1 second of the video is equivalent to 25
minutes of real time). A field of 100 mm width is shown.
Found at: doi:10.1371/journal.ppat.1000945.s005 (5.46 MB AVI)
Video S6 Macrophage fusion after C. neoformans phagocytosis
and cell division. RAW264.7 macrophage cell lines were exposed
to C. neoformans H99 strain at a ratio 1:2. Videos were performed as
described in Materials and Methods. Pictures were taken every 5
minutes, and 5 frames per second are shown in the video (1 second
of the video is equivalent to 25 minutes of real time). A field of
100 mm width is shown.
Found at: doi:10.1371/journal.ppat.1000945.s006 (6.16 MB AVI)
Video S7 C. neoformans intracellular replication. Macrophages
and C. neoformans grown in Sabouraud were mixed as described in
supplemental Videos S5 and S6. The pictures were taken every 2
minutes, and 5 frames per seconds are shown in the video (1
second of the video is equivalent to 10 minutes of real time).
Found at: doi:10.1371/journal.ppat.1000945.s007 (6.16 MB AVI)
Video S8 Interaction between giant cells and macrophages.
Macrophages and C. neoformans giant cells were mixed at 1:2 ratio
as described in Materials and Methods. Pictures were taken every
3 minutes, and 5 frames per second are shown in the video (1
second of the video is equivalent to 15 minutes of real time). A field
of 100 mm width is shown.
Found at: doi:10.1371/journal.ppat.1000945.s008 (5.09 MB AVI)
Video S9 Interaction between giant cells and macrophages.
Macrophages and C. neoformans giant cells were mixed at 1:2 ratio
as described in Materials and Methods. Pictures and video were
taken and assemble as described in Supporting Video S8. Scale
bar denotes 50 mm.
Found at: doi:10.1371/journal.ppat.1000945.s009 (2.04 MB
WMV)
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